Lupin, Cipla and Aurobindo: Axis Securities advises to buy these 3 pharma firms after Q1 earnings – key reasons
HDFC Securities prefers economy-facing and value sectors after Q1 earnings; a look at top changes in its model portfolio
Retail Q1 review: Axis Securities lists top stocks to buy after results